Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 208615
Company: SCINOPHARM TAIWAN

Products on ANDA 208615

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
FONDAPARINUX SODIUM	FONDAPARINUX SODIUM	2.5MG/0.5ML	SOLUTION;SUBCUTANEOUS	Prescription	AP	No	No
FONDAPARINUX SODIUM	FONDAPARINUX SODIUM	5MG/0.4ML	SOLUTION;SUBCUTANEOUS	Prescription	AP	No	No
FONDAPARINUX SODIUM	FONDAPARINUX SODIUM	7.5MG/0.6ML	SOLUTION;SUBCUTANEOUS	Prescription	AP	No	No
FONDAPARINUX SODIUM	FONDAPARINUX SODIUM	10MG/0.8ML	SOLUTION;SUBCUTANEOUS	Prescription	AP	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 208615

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
11/14/2018	ORIG-1	Approval		STANDARD		Label is not available on this site.

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
09/12/2023	SUPPL-3	Labeling-Medication Guide, Labeling-Package Insert		Label is not available on this site.

Therapeutic Equivalents for ANDA 208615

FONDAPARINUX SODIUM

SOLUTION;SUBCUTANEOUS; 2.5MG/0.5ML
TE Code = AP

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
ARIXTRA	FONDAPARINUX SODIUM	2.5MG/0.5ML	SOLUTION;SUBCUTANEOUS	Prescription	Yes	AP	021345	MYLAN IRELAND LTD
FONDAPARINUX SODIUM	FONDAPARINUX SODIUM	2.5MG/0.5ML	SOLUTION;SUBCUTANEOUS	Prescription	No	AP	091316	DR REDDYS LABS LTD
FONDAPARINUX SODIUM	FONDAPARINUX SODIUM	2.5MG/0.5ML	SOLUTION;SUBCUTANEOUS	Prescription	No	AP	206918	EUGIA PHARMA
FONDAPARINUX SODIUM	FONDAPARINUX SODIUM	2.5MG/0.5ML	SOLUTION;SUBCUTANEOUS	Prescription	No	AP	206812	HENGRUI PHARMA
FONDAPARINUX SODIUM	FONDAPARINUX SODIUM	2.5MG/0.5ML	SOLUTION;SUBCUTANEOUS	Prescription	No	AP	208615	SCINOPHARM TAIWAN

SOLUTION;SUBCUTANEOUS; 5MG/0.4ML
TE Code = AP

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
ARIXTRA	FONDAPARINUX SODIUM	5MG/0.4ML	SOLUTION;SUBCUTANEOUS	Prescription	Yes	AP	021345	MYLAN IRELAND LTD
FONDAPARINUX SODIUM	FONDAPARINUX SODIUM	5MG/0.4ML	SOLUTION;SUBCUTANEOUS	Prescription	No	AP	091316	DR REDDYS LABS LTD
FONDAPARINUX SODIUM	FONDAPARINUX SODIUM	5MG/0.4ML	SOLUTION;SUBCUTANEOUS	Prescription	No	AP	206918	EUGIA PHARMA
FONDAPARINUX SODIUM	FONDAPARINUX SODIUM	5MG/0.4ML	SOLUTION;SUBCUTANEOUS	Prescription	No	AP	206812	HENGRUI PHARMA
FONDAPARINUX SODIUM	FONDAPARINUX SODIUM	5MG/0.4ML	SOLUTION;SUBCUTANEOUS	Prescription	No	AP	208615	SCINOPHARM TAIWAN

SOLUTION;SUBCUTANEOUS; 7.5MG/0.6ML
TE Code = AP

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
ARIXTRA	FONDAPARINUX SODIUM	7.5MG/0.6ML	SOLUTION;SUBCUTANEOUS	Prescription	Yes	AP	021345	MYLAN IRELAND LTD
FONDAPARINUX SODIUM	FONDAPARINUX SODIUM	7.5MG/0.6ML	SOLUTION;SUBCUTANEOUS	Prescription	No	AP	091316	DR REDDYS LABS LTD
FONDAPARINUX SODIUM	FONDAPARINUX SODIUM	7.5MG/0.6ML	SOLUTION;SUBCUTANEOUS	Prescription	No	AP	206918	EUGIA PHARMA
FONDAPARINUX SODIUM	FONDAPARINUX SODIUM	7.5MG/0.6ML	SOLUTION;SUBCUTANEOUS	Prescription	No	AP	206812	HENGRUI PHARMA
FONDAPARINUX SODIUM	FONDAPARINUX SODIUM	7.5MG/0.6ML	SOLUTION;SUBCUTANEOUS	Prescription	No	AP	208615	SCINOPHARM TAIWAN

SOLUTION;SUBCUTANEOUS; 10MG/0.8ML
TE Code = AP

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
ARIXTRA	FONDAPARINUX SODIUM	10MG/0.8ML	SOLUTION;SUBCUTANEOUS	Prescription	Yes	AP	021345	MYLAN IRELAND LTD
FONDAPARINUX SODIUM	FONDAPARINUX SODIUM	10MG/0.8ML	SOLUTION;SUBCUTANEOUS	Prescription	No	AP	091316	DR REDDYS LABS LTD
FONDAPARINUX SODIUM	FONDAPARINUX SODIUM	10MG/0.8ML	SOLUTION;SUBCUTANEOUS	Prescription	No	AP	206918	EUGIA PHARMA
FONDAPARINUX SODIUM	FONDAPARINUX SODIUM	10MG/0.8ML	SOLUTION;SUBCUTANEOUS	Prescription	No	AP	206812	HENGRUI PHARMA
FONDAPARINUX SODIUM	FONDAPARINUX SODIUM	10MG/0.8ML	SOLUTION;SUBCUTANEOUS	Prescription	No	AP	208615	SCINOPHARM TAIWAN